Blackstone’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
Other funds holding ACET
Blackstone's ACET Position: Q2 2025 in Review
Blackstone sold out of Adicet Bio (ACET) in Q2 2025, closing a stake of 77,278 shares — an estimated $934K sold.
Blackstone first reported a position in ACET in Q1 2024 and held it in 5 quarters. The position peaked at $2.91M in Q1 2024. 49 funds tracked by Wall St. Rank hold ACET as of Q2 2025.
- Blackstone reported no remaining Adicet Bio position as of Q2 2025 after selling out during the quarter.
- Blackstone sold 77,278 Adicet Bio shares in Q2 2025, an estimated $934K.
- Blackstone first reported a position in Adicet Bio in Q1 2024 and held it in 5 quarters.
- Blackstone's Adicet Bio position peaked at $2.91M in Q1 2024.
- 49 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2025.
Based on Blackstone's 13F filing for Q2 2025, filed 14 Aug 2025.